Ticker: KALV

Company: Carbylan Therapeutics, Inc.

Person: Benjamin L Palleiko, director, officer

Transaction date: Nov. 21, 2025

Reporting date: Nov. 26, 2025

Average share price: -11.954016246953696

Sold 12310.0 shares for 147153.94